nach oben

vorheriger Artikel Correction to: Knock-on effect of periodontitis...

nächster Artikel MUW researcher of the month

Tipp

Clinical-Pathological Conference Series from the Medical University of Graz

Case No 171: A 37-year-old engineer with bolus hold-up (esophageal food impaction)

Zeitschrift:: Wiener klinische Wochenschrift > Ausgabe 17-18/2020

Autoren:: MD, PhD, MSc, BSc Elisabeth Fabian, MD Hans Peter Gröchenig, MD Philipp K. Bauer, MD Andreas J. Eherer, MD Markus Gugatschka, MD Lukas Binder, MD Cord Langner, MD Peter Fickert, MD, AGAF, MWGO Guenter J. Krejs

» Zum Volltext PDF-Version jetzt herunterladen

Wichtige Hinweise

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Without Abstract

Unsere Produktempfehlungen

Abo für kostenpflichtige Inhalte

Jetzt informieren

Jameson JL, Fauci AS, Kasper DL, Hauser SL, Longo DL, Loscalzo J. Harrison’s principles of internal medicine. 20th ed. New York: McGraw-Hill; 2018.

Johnston BT. Oesophageal dysphagia: a stepwise approach to diagnosis and management. Lancet Gastroenterol Hepatol. 2017;2(8):604–9. PubMed

Edwards DA. Discriminative information in the diagnosis of dysphagia. J R Coll Physicians Lond. 1975;9(3):257–63. PubMedPubMedCentral

Cook IJ. Diagnostic evaluation of dysphagia. Nat Clin Pract Gastroenterol Hepatol. 2008;5(7):393–403. PubMed

Blonski W, Vela M, Safder A, Hila A, Castell DO. Revised criterion for diagnosis of ineffective esophageal motility is associated with more frequent dysphagia and greater bolus transit abnormalities. Am J Gastroenterol. 2008;103(3):699–704. PubMed

Roman S, Lin Z, Kwiatek MA, Pandolfino JE, Kahrilas PJ. Weak peristalsis in esophageal pressure topography: classification and association with dysphagia. Am J Gastroenterol. 2011;106(2):349–56. PubMed

Ratuapli SK, Crowell MD, DiBaise JK, Vela MF, Ramirez FC, Burdick GE, et al. Opioid-induced esophageal dysfunction (OIED) in patients on chronic opioids. Am J Gastroenterol. 2015;110(7):979–84. PubMed

Shaheen NJ, Hansen RA, Morgan DR, Gangarosa LM, Ringel Y, Thiny MT, et al. The burden of gastrointestinal and liver diseases, 2006. Am J Gastroenterol. 2006;101(9):2128–38. PubMed

Kahrilas PJ. Gastroesophageal reflux disease. N Engl J Med. 2008;359(16):1700–7. PubMedPubMedCentral

10.

Cho SY, Choung RS, Saito YA, Schleck CD, Zinsmeister AR, Locke GR 3rd, et al. Prevalence and risk factors for dysphagia: a USA community study. Neurogastroenterol Motil. 2015;27(2):212–9. PubMed

11.

Vakil NB, Traxler B, Levine D. Dysphagia in patients with erosive esophagitis: prevalence, severity, and response to proton pump inhibitor treatment. Clin Gastroenterol Hepatol. 2004;2(8):665–8. PubMed

12.

Dakkak M, Hoare RC, Maslin SC, Bennett JR. Oesophagitis is as important as oesophageal stricture diameter in determining dysphagia. Gut. 1993;34(2):152–5. PubMedPubMedCentral

13.

Katz PO, Gerson LB, Vela MF. Guidelines for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol. 2013;108(3):308–28. PubMed

14.

Stoschus B, Allescher HD. Drug-induced dysphagia. Dysphagia. 1993;8(2):154–9. PubMed

15.

Gröchenig HP, Tilg H, Vogetseder W. Clinical challenges and images in GI. Pill esophagitis. Gastroenterology. 2006;131(4):996–1365. PubMed

16.

Abe Y, Sasaki Y, Yagi M, Yaoita T, Nishise S, Ueno Y. Diagnosis and treatment of eosinophilic esophagitis in clinical practice. Clin J Gastroenterol. 2017;10(2):87–102. PubMed

17.

Lynch KL, Dhalla S, Chedid V, Ravich WJ, Stein EM, Montgomery EA, et al. Gender is a determinative factor in the initial clinical presentation of eosinophilic esophagitis. Dis Esophagus. 2016;29(2):174–8. PubMed

18.

Arias Á, Pérez-Martínez I, Tenías JM, Lucendo AJ. Systematic review with meta-analysis: the incidence and prevalence of eosinophilic oesophagitis in children and adults in population-based studies. Aliment Pharmacol Ther. 2016;43(1):3–15. PubMed

19.

Liacouras CA, Furuta GT, Hirano I, Atkins D, Attwood SE, Bonis PA, et al. Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol. 2011;128(1):3–20.e6. PubMed

20.

Hirano I. How to approach a patient with eosinophilic esophagitis. Gastroenterology. 2018;155(3):601–6. PubMed

21.

Desai TK, Stecevic V, Chang CH, Goldstein NS, Badizadegan K, Furuta GT. Association of eosinophilic inflammation with esophageal food impaction in adults. Gastrointest Endosc. 2005;61:795–801. PubMed

22.

Kim HP, Vance RB, Shaheen NJ, Dellon ES. The prevalence and diagnostic utility of endoscopic features of eosinophilic esophagitis: a meta-analysis. Clin Gastroenterol Hepatol. 2012;10(9):988–996.e5. PubMedPubMedCentral

23.

Lucendo AJ, Molina-Infante J, Arias Á, von Arnim U, Bredenoord AJ, Bussmann C, et al. Guidelines on eosinophilic esophagitis: evidence-based statements and recommendations for diagnosis and management in children and adults. United European Gastroenterol J. 2017;5(3):335–58. PubMedPubMedCentral

24.

Aggestrup S, Uddman R, Jensen SL, Sundler F, Schaffalitzky de Muckadell O, Holst JJ, et al. Regulatory peptides in the lower esophageal sphincter of man. Regul Pept. 1985;10:167–78. PubMed

25.

Mearin F, Mourelle M, Guarner F, Salas A, Riveros-Moreno V, Moncada S, et al. Patients with achalasia lack nitric oxide synthase in the gastro-oesophageal junction. Eur J Clin Invest. 1993;23:724–8. PubMed

26.

Clark SB, Rice TW, Tubbs RR, Richter JE, Goldblum JR. The nature of the myenteric infiltrate in achalasia: an immunohistochemical analysis. Am J Surg Pathol. 2000;24:1153–8. PubMed

27.

Boeckxstaens GE. The lower esophageal sphincter. Neurogastroenterol Motil. 2005;17(Suppl 1):13–21. PubMed

28.

Ates F, Vaezi MF. The pathogenesis and management of achalasia: current status and future directions. Gut Liver. 2015;9:449–63. PubMedPubMedCentral

29.

Gockel I, Bohl JR, Eckardt VF, Junginger T. Reduction of interstitial cells of Cajal (ICC) associated with neuronal nitric oxide synthase (n-NOS) in patients with achalasia. Am J Gastroenterol. 2008;103(4):856–64. PubMed

30.

Gockel I, Bohl JR, Doostkam S, Eckardt VF, Junginger T. Spectrum of histopathologic findings in patients with achalasia reflects different etiologies. J Gastroenterol Hepatol. 2006;21:727–33. PubMed

31.

Pandolfino JE, Gawron AJ. Achalasia: a systematic review. JAMA. 2015;313:1841–52. PubMed

32.

Howard PJ, Maher L, Pryde A, Cameron EW, Heading RC. Five year prospective study of the incidence, clinical features, and diagnosis of achalasia in Edinburgh. Gut. 1992;33:1011–5. PubMedPubMedCentral

33.

Eckardt VF. Clinical presentations and complications of achalasia. Gastrointest Endosc Clin N Am. 2001;11:281–92. PubMed

34.

Fisichella PM, Raz D, Palazzo F, Niponmick I, Patti MG. Clinical, radiological, and manometric profile in 145 patients with untreated achalasia. World J Surg. 2008;32:1974–9. PubMed

35.

Eckardt VF, Stauf B, Bernhard G. Chest pain in achalasia: patient characteristics and clinical course. Gastroenterology. 1999;116:1300–4. PubMed

36.

Massey BT, Hogan WJ, Dodds WJ, Dantas RO. Alteration of the upper esophageal sphincter belch reflex in patients with achalasia. Gastroenterology. 1992;103:1574–9. PubMed

37.

Seeman H, Traube M. Hiccups and achalasia. Ann Intern Med. 1991;115:711–2. PubMed

38.

Spechler SJ, Souza RF, Rosenberg SJ, Ruben RA, Goyal RK. Heartburn in patients with achalasia. Gut. 1995;37:305–8. PubMedPubMedCentral

39.

Richter JE. The diagnosis and misdiagnosis of achalasia: it does not have to be so difficult. Clin Gastroenterol Hepatol. 2011;9:1010–1. PubMed

40.

Spechler SJ, Castell DO. Classification of oesophageal motility abnormalities. Gut. 2001;49:145–51. PubMedPubMedCentral

41.

Vaezi MF, Richter JE. Diagnosis and management of achalasia. American College of Gastroenterology Practice Parameter Committee. Am J Gastroenterol. 1999;94:3406–12. PubMed

42.

Francis DL, Katzka DA. Achalasia: update on the disease and its treatment. Gastroenterology. 2010;139:369–74. PubMed

43.

Kahrilas PJ, Bredenoord AJ, Fox M, Gyawali CP, Roman S, Smout AJPM, et al. Expert consensus document: advances in the management of oesophael motility disorders in the era of high-resolution manometry: a focus on achalasia syndromes. Nat Rev Gastroenterol Hepatol. 2017;14:677–88. PubMed

44.

Fabian E, Eherer AJ, Lackner C, Urban C, Smolle-Juettner FM, Krejs GJ. Pseudoachalasia as first manifestation of a malignancy. Dig Dis. 2019;37(5):347–54. PubMed

45.

Yuan SM. Cardiovascular dysphagia—anatomical and clinical implications. Folia Morphol (Warsz). 2014;73(2):113–21.

46.

Dellon ES, Liacouras CA, Molina-Infante J, Furuta GT, Spergel JM, Zevit N, et al. Updated international consensus diagnostic criteria for eosinophilic esophagitis: proceedings of the AGREE conference. Gastroenterology. 2018;155(4):1022–1033.e10. PubMedPubMedCentral

47.

Winter HS, Madara JL, Stafford RJ, Grand RJ, Quinlan JE, Goldman H. Intraepithelial eosinophils: a new diagnostic criterion for reflux esophagitis. Gastroenterology. 1982;83(4):818–23. PubMed

48.

Parfitt JR, Gregor JC, Suskin NG, Jawa HA, Driman DK. Eosinophilic esophagitis in adults: distinguishing features from gastroesophageal reflux disease: a study of 41 patients. Mod Pathol. 2006;19(1):90–6. PubMed

49.

Krejs GJ, Seefeld U, Braendli HH, Bron BA, Caro G, Schmid P, et al. Gastro-esophageal reflux disease: correlation of subjective symptoms with 7 objective esophageal function tests. Acta Hepatogastroenterol. 1976;23:130–40.

50.

Seefeld U, Krejs GJ, Siebenmann RE, Blum AL. Esophageal histology in gastroesophageal reflux. Morphometric findings in suction biopsies. Am J Dig Dis. 1977;22:956–64. PubMed

51.

Bussmann C, Straumann A. Eosinophilic esophagitis: the diagnostic contribution of pathology. Pathologe. 2013;34(2):110–7. PubMed

52.

Dellon ES, Speck O, Woodward K, Covey S, Rusin S, Shaheen NJ, et al. Distribution and variability of esophageal eosinophilia in patients undergoing upper endoscopy. Mod Pathol. 2015;28(3):383–90. PubMed

53.

Salek J, Clayton F, Vinson L, Saffari H, Pease LF 3rd, Boynton K, et al. Endoscopic appearance and location dictate diagnostic yield of biopsies in eosinophilic oesophagitis. Aliment Pharmacol Ther. 2015;41(12):1288–95. PubMed

54.

Sherrill JD, Rothenberg ME. Genetic dissection of eosinophilic esophagitis provides insight into disease pathogenesis and treatment strategies. J Allergy Clin Immunol. 2011;128(1):23–32. PubMedPubMedCentral

55.

Holvoet S, Blanchard C. Genetic and molecular mechanisms leading to eosinophilic esophagitis. Rev Esp Enferm Dig. 2014;106(4):276–80. PubMed

56.

Comeau MR, Ziegler SF. The influence of TSLP on the allergic response. Mucosal Immunol. 2010;3(2):138–47. PubMed

57.

Rothenberg ME, Mishra A, Brandt EB, Hogan SP. Gastrointestinal eosinophils. Immunol Rev. 2001;179:139–55. PubMed

58.

Blanchard C, Wang N, Stringer KF, Mishra A, Fulkerson PC, Abonia JP, et al. Eotaxin‑3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis. J Clin Invest. 2006;116(2):536–47. PubMedPubMedCentral

59.

Blanchard C, Stucke EM, Burwinkel K, Caldwell JM, Collins MH, Ahrens A, et al. Coordinate interaction between IL-13 and epithelial differentiation cluster genes in eosinophilic esophagitis. J Immunol. 2010;184(7):4033–41. PubMed

60.

Dellon ES, Gibbs WB, Fritchie KJ, Rubinas TC, Wilson LA, Woosley JT, et al. Clinical, endoscopic, and histologic findings distinguish eosinophilic esophagitis from gastroesophageal reflux disease. Clin Gastroenterol Hepatol. 2009;7(12):1305–13. PubMedPubMedCentral

61.

Hirano I, Furuta GT. Approaches and challenges to management of pediatric and adult patients with eosinophilic esophagitis. Gastroenterology. 2020;158:840–51. PubMed

62.

Gonsalves N, Yang GY, Doerfler B, Ritz S, Ditto AM, Hirano I. Elimination diet effectively treats eosinophilic esophagitis in adults; food reintroduction identifies causative factors. Gastroenterology. 2012;142(7):1451–1459.e1. PubMed

63.

Arias A, González-Cervera J, Tenias JM, Lucendo AJ. Efficacy of dietary interventions for inducing histologic remission in patients with eosinophilic esophagitis: a systematic review and meta-analysis. Gastroenterology. 2014;146(7):1639–48. PubMed

64.

Dellon ES, Speck O, Woodward K, Gebhart JH, Madanick RD, Levinson S, et al. Clinical and endoscopic characteristics do not reliably differentiate PPI-responsive esophageal eosinophilia and eosinophilic esophagitis in patients undergoing upper endoscopy: a prospective cohort study. Am J Gastroenterol. 2013;108(12):1854–60. PubMedPubMedCentral

65.

Spechler SJ, Genta RM, Souza RF. Thoughts on the complex relationship between gastroesophageal reflux disease and eosinophilic esophagitis. Am J Gastroenterol. 2007;102(6):1301–6. PubMed

66.

van Rhijn BD, Weijenborg PW, Verheij J, van den Bergh Weerman MA, Verseijden C, van den Wijngaard RM, et al. Proton pump inhibitors partially restore mucosal integrity in patients with proton pump inhibitor-responsive esophageal eosinophilia but not eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2014;12(11):1815–23. PubMed

67.

Kedika RR, Souza RF, Spechler SJ. Potential anti-inflammatory effects of proton pump inhibitors: a review and discussion of the clinical implications. Dig Dis Sci. 2009;54(11):2312–7. PubMedPubMedCentral

68.

Cheng E, Zhang X, Huo X, Yu C, Zhang Q, Wang DH, et al. Omeprazole blocks eotaxin‑3 expression by oesophageal squamous cells from patients with eosinophilic oesophagitis and GORD. Gut. 2013;62(6):824–32. PubMed

69.

Lucendo AJ, Miehlke S, Schlag C, Vieth M, von Armin U, Molina-Infante J, et al. International EOS‑1 study group. Efficacy of budesonide orodispersible tablets as induction therapy for eosinophilic esophagitis in a randomized placebo-controlled trial. Gastroenterology. 2019;157:74–86.e15. PubMed

70.

Dellon ES, Katzka DA, Collins MH, Hamdani M, Gupta SK, Hirano I, et al. Budesonide oral suspension improves symptomatic, endoscopic, and histologic parameters compared with placebo in patients with eosinophilic esophagitis. Gastroenterology. 2017;152:776–786.e5. PubMed

71.

Dellon ES. Diagnosis and management of eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2012;10(10):1066–78. PubMedPubMedCentral

72.

Straumann A, Conus S, Degen L, Frei C, Bussmann C, Beglinger C, et al. Long-term budesonide maintenance treatment is partially effective for patients with eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2011;9(5):400–409.e1. PubMed

73.

Lucendo AJ, Arias A, De Rezende LC, Yagüe-Compadre JL, Mota-Huertas T, González-Castillo S, et al. Subepithelial collagen deposition, profibrogenic cytokine gene expression, and changes after prolonged fluticasone propionate treatment in adult eosinophilic esophagitis: a prospective study. J Allergy Clin Immunol. 2011;128(5):1037–46. PubMed

74.

Rank MA, Sharaf RN, Furuta GT, Aceves SS, Greenhawt M, Spergel JM, et al. Technical review on the management of eosinophilic esophagitis: a report from the AGA Institute and the Joint Task Force on Allergy-Immunology Practice Parameters. Gastroenterology. 2020;124(5):424–440.e17.

75.

Liguori G, Cortale M, Cimino F, Sozzi M. Circumferential mucosal dissection and esophageal perforation in a patient with eosinophilic esophagitis. World J Gastroenterol. 2008;14(5):803–4. PubMedPubMedCentral

76.

Attwood SE, Smyrk TC, Demeester TR, Jones JB. Esophageal eosinophilia with dysphagia. A distinct clinicopathologic syndrome. Dig Dis Sci. 1993;38(1):109–16. PubMed

77.

Straumann A, Spichtin HP, Bernoulli R, Loosli J, Vögtlin J. Idiopathic eosinophilic esophagitis: a frequently overlooked disease with typical clinical aspects and discrete endoscopic findings. Schweiz Med Wochenschr. 1994;124(33):1419–29. PubMed

Titel: Clinical-Pathological Conference Series from the Medical University of Graz
Case No 171: A 37-year-old engineer with bolus hold-up (esophageal food impaction)
Autoren:: MD, PhD, MSc, BSc Elisabeth Fabian
MD Hans Peter Gröchenig
MD Philipp K. Bauer
MD Andreas J. Eherer
MD Markus Gugatschka
MD Lukas Binder
MD Cord Langner
MD Peter Fickert
MD, AGAF, MWGO Guenter J. Krejs
Publikationsdatum: 29.06.2020
DOI: https://doi.org/10.1007/s00508-020-01694-x
Verlag: Springer Vienna
Zeitschrift: Wiener klinische Wochenschrift The Central European Journal of Medicine
Ausgabe 17-18/2020
Print ISSN: 0043-5325
Elektronische ISSN: 1613-7671

Springer Medizin Österreich

Tipp

Weitere Artikel dieser Ausgabe durch Wischen aufrufen

Clinical-Pathological Conference Series from the Medical University of Graz

Case No 171: A 37-year-old engineer with bolus hold-up (esophageal food impaction)

Publisher’s Note

Without Abstract

Unsere Produktempfehlungen

Abo für kostenpflichtige Inhalte

Springer Medizin Österreich

Tipp

Weitere Artikel dieser Ausgabe durch Wischen aufrufen

Publisher’s Note

Without Abstract

Unsere Produktempfehlungen

Abo für kostenpflichtige Inhalte

Weitere Artikel der Ausgabe 17-18/2020

Management and outcome of traumatic subdural hematoma in 47 infants and children from a single center

Outcome after intravenous thrombolysis in embolic stroke of undetermined source compared to cardioembolic stroke

Veranstaltungstipps

Correction to: Knock-on effect of periodontitis to the pathogenesis of Alzheimer’s disease?

MUW researcher of the month

Acute amnestic syndrome with hippocampal lesion due to influenza B-associated encephalopathy